Presentation of asymptomatic primary hyperparathyroidism: Proceedings of the Third International Workshop

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 2, 2009, Pages 351-365

  Silverberg, Shonni J ^a   Lewiecki, E Michael ^b   Mosekilde, Leif ^c   Peacock, Munro ^d   Rubin, Mishaela R ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b NEW MEXICO CLINICAL RESEARCH AND OSTEOPOROSIS CENTER   (United States)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CREATININE; PARATHYROID HORMONE;

BONE DENSITY; CALCIFICATION; CARDIOVASCULAR DISEASE; CAROTID ARTERY OBSTRUCTION; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONSENSUS; CORONARY ARTERY DISEASE; DISEASE SEVERITY; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HYPERCALCIURIA; HYPERTENSION; MORTALITY; MYOCARDIAL DISEASE; NEPHROLITHIASIS; NEUROPSYCHOLOGY; PARATHYROIDECTOMY; PHENOTYPE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; VALVULAR HEART DISEASE;

EID: 59749099024     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-1760     Document Type: Conference Paper

References (106)

1. Bilezikian JP, Potts Jr JT, El-Hajj Fuleihan G, Kleerekoper M, Neer R, Peacock M, Rastad J, Silverberg SJ, Udelsman R, Wells Jr SA 2002 Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Min Res 17(Suppl 2): N2-N11,
2. and J Clin Endocrinol Metab 87:5353-5361
3. Palmer M, Adami HO, Bergstrom R, Akerstrom G, Ljunghall S 1987 Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 102:1-7
4. Ronni-Sivula H 1985 Causes of death in patients previously operated on for primary hyperparathyroidism. Ann Chir Gynaecol 74:13-18
5. Hedback G, Tisell LE, Bengtsson BA, Hedman I, Oden A 1990 Premature death in patients operated on for primary hyperparathyroidism. World J Surg 14:829-835; discussion, 836
6. Ljunghall S, Jakobsson S, Joborn C, Palmer M, Rastad J, Akerstrom G 1991 Longitudinal studies of mild primary hyperparathyroidism. J Bone Miner Res 6(Suppl 2):S111-S116; discussion, S121-S124
7. Hedbäck G, Odén A, Tisell LE 1991 The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 15:399-405; discussion, 406-407
8. Soreide JA, van Heerden JA, Grant CS, Yau Lo C, Schleck C, Ilstrup DM 1997 Survival after surgical treatment for primary hyperparathyroidism. Surgery 122:1117-1123
9. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon M, Melton III LJ 1998 Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med 104:115-122
10. Nilsson IL, Yin L, Lundgren E, Rastad J, Ekbom A 2002 Clinical presentation of primary hyperparathyroidism in Europe-nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res 17(Suppl 2):N68-N74
11. Hedbäck G, Odén A 1998 Increased risk of death from primary hyperparathyroidism - an update. Eur J Clin Invest 28:271-276
12. Hedbäck GM, Odén AS 2002 Cardiovascular disease, hypertension and renal function in primary hyperparathyroidism. J Intern Med 251:476-483
13. Øgard CG, Engholm G, Almdal TP, Vestergaard H 2004 Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark. World J Surg 28:108-111
14. Nainby-Luxmoore JC, Langford HG, Nelson NC, Watson RL, Barnes TY 1982 A case-comparison study of hypertension and hyperparathyroidism. J Clin Endocrinol Metab 55:303-306
15. Ringe JD 1984 Reversible hypertension in primary hyperparathyroidism - pre- and postoperative blood pressure in 75 cases. Klin Wochenschr 62:465-469
16. Rapado A 1986 Arterial hypertension and primary hyperparathyroidism. Incidence and follow-up after parathyroidectomy. Am J Nephrol 6(Suppl 1):49 -50
17. Lind L, Jacobsson S, Palmer M, Lithell H, Wengle B, Ljunghall S 1991 Cardiovascular risk factors in primary hyperparathyroidism: a 15-year follow-up of operated and unoperated cases. J Intern Med 230:29-35
18. Lind L, Skarfors E, Berglund L, Lithell H, Ljunghall S 1997 Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J Clin Epidemiol 50:967-973
19. Kamycheva E, Sundsfjord J, Jorde R 2004 Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study. Eur J Cardiovasc Prev Rehabil 11:69-74
20. Roberts WC, Waller BF 1981 Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients. Am J Med 71:371-384
21. Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L 2003 Cardiovascular events before and after surgery for primary hyperparathyroidism. World J Surg 27:216-222
22. Nilsson IL, Aberg J, Rastad J, Lind L 2005 Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery 137:632-638
23. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B 1993 Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 95:197-202
24. Dalberg K, Brodin LA, Juhlin-Dannfelt A, Farnebo LO 1996 Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur J Surg 162:171-176
25. Nuzzo V, Tauchmanova L, Fonderico F, Trotta R, Fittipaldi MR, Fontanta D, Rossi R, Lombardi G, Trimarco B, Lupoli G 2002 Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol 147:453-459
26. Nilsson IL, Aberg J, Rastad J, Lind L 2000 Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism - effects of parathyroidectomy. Surgery 128:895-902
27. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F, Borretta G 1999 Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 50:321-328
28. Almqvist EG, Bondeson AG, Bondeson L, Nissborg A, Smedgard P, Svensson SE 2002 Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery 132:1126-1132; discussion, 1132
29. Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, Niederle B 1997 Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 82:106-112
30. Ogard CG, Søndergaard SB, Vestergaard H, Jakobsen H, Nielsen SL 2005 Myocardial perfusion defects and the left ventricular ejection fraction disclosed by scintigraphy in patients with primary hyperparathyroidism. World J Surg 29:914-916
31. Lind L, Ridefelt P, Rastad J, Akerstrom G, Ljunghall S 1994 Cytoplasmic calcium regulation and the electrocardiogram in patients with primary hyperparathyroidism. Clin Physiol 14:103-110
32. Rosenqvist M, Nordenstrom J, Andersson M, Edhag OK 1992 Cardiac conduction in patients with hypercalcaemia due to primary hyperparathyroidism. Clin Endocrinol (Oxf) 37:29-33
33. Barletta G, De Feo ML, Del Bene R, Lazzeri C, Vecchiarino S, La Villa G, Brandi ML, Franchi F 2000 Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J Clin Endocrinol Metab 85:1815-1821
34. Curione M, Letizia C, Amato S, Di Bona S, Di Fazio F, Minisola S, Mazzzuoli G, D'Erasmo E 2007 Increased risk of cardiac death in primary hyperparathyroidism: what is a role of electrical instability? Int J Cardiol 121:200-202
35. Baykan M, Erem C, Erdogan T, Ersoz HÖ, Gedikli Ö, Korkmaz L, Kücükosmanoglu M, Haclhasanoglu A, Kaplan S, Celik S 2007 Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 66:483-488
36. Rubin MR, Rundek T, McMahon DJ, Lee HS, Sacco RL, Silverberg SJ 2007 Carotid artery plaque thickness is associated with increased serum calcium levels: the Northern Manhattan study. Atherosclerosis 194:426-432
37. Nilsson IL, Aberg J, Rastad J, Lind L 1999 Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 126:1049-1055
38. Kosch M, Hausberg M, Vormbrock K, Kisters K, Rahn KH, Barenbrock M 2000 Studies on flow-mediated vasodilation and intima-media thickness of the brachial artery in patients with primary hyperparathyroidism. Am J Hypertens 13:759-764
39. Lumachi F, Ermani M, Frego M, Pilon F, Filosa T, Di Cristofaro L, De Lotto F, Fallo F 2006 Intima-media thickness measurement of the carotid artery in patients with primary hyperparathyroidism.Aprospective case-control study and long-term follow-up. In Vivo 20:887-890
40. Fallo F, Camporese G, Capitelli E, Andreozzi GM, Mantero F, Lumachi F 2003 Ultrasound evaluation of carotid artery in primary hyperparathyroidism. J Clin Endocrinol Metab 88:2096-2099
41. Neunteufl T, Katzenschlager R, Abela C, Kostner K, Niederie B, Weidinger F, Stefenelli T 1998 Impairment of endothelium-independent vasodilation in patients with hypercalcemia. Cardiovasc Res 40:396-401
42. Kosch M, Hausberg M, Vormbrock K, Kisters K, Gabriels G, Rahn KH, Barencrobk M 2000 Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 47:813-818
43. Baykan M, Erem C, Erdogan T, Hacihasanoglu A, Gedikli O, Kiris A, Kucukosmanoglu M, Ersoz HO, Celik S 2007 Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int J Cardiovasc Imaging 23:323-328
44. Smith JC, Page MD, John R, Wheeler MH, Cockcroft JR, Scanlon MF, Davies JS 2000 Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 85:3515-3519
45. Rubin MR, Maurer MS, McMahon DJ, Bilezikian JP, Silverberg SJ 2005 Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab 90:3326-3330
46. Brown GG, Preisman RC, Kleerekoper M 1987 Neurobehavioral symptoms in mild primary hyperparathyroidism: related to hypercalcemia but not improved by parathyroidectomy. Henry Ford Hosp Med J 35:211-215
47. Burney RE, Jones KR, Christy B, Thompson NW 1999 Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 125:608-614
48. Caillard C, Sebag F, Mathonnet M, Gibelin H, Brunaud L, Loudot C, Kraimps JL, Hamy A, Bresler L, Charbonnel B, Leborgne J, Henry JF, Nguyen JM, Mirallie E 2007 Prospective evaluation of quality of life (SF-36v2) and non-specific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery 141:153-159; discussion, 159-160
49. Dotzenrath CM, Kaetsch AK, Pfingsten H, Cupisti K, Weyerbrock N, Vossough A, Verde PE, Ohmann C 2006 Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World J Surg 5:680-685
50. Eigelberger MS, Cheah WK, Ituarte PH, Streja L, Duh QY, Clark OH 2004 The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg 239:528-535
51. Joborn C, Hetta J, Lind L, Rastad J, Akerstrom G, Ljunghall S 1989 Self-rated psychiatric symptoms in patients operated on because of primary hyperparathyroidism and in patients with long-standing mild hypercalcemia. Surgery 105:72-78
52. Numann PJ, Torppa AJ, Blumetti AE 1984 Neuropsychologic deficits associated with primary hyperparathyroidism. Surgery 96:1119-1123
53. Pasieka JL, Parsons LL 1998 Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22:513-518; discussion, 518-519
54. Prager G, Kalaschek A, Kaczirek K, Passler C, Scheuba C, Sonneck G, Niederle B 2002 Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery 132:930-935; discussion, 935-936
55. Roman SA, Sosa JA, Mayes L, Desmond E, Boudourakis L, Lin R, Snyder PJ, Holt E, Udelsman R 2005 Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery 138:1121-1128; discussion, 1128-1129
56. Solomon BL, Schaaf M, Smallridge RC 1994 Psychologic symptoms before and after parathyroid surgery. Am J Med 96:101-106
57. Pasieka JL, Parsons LL 2000 A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism. Surgery 128:531-539
58. Pasieka JL, Parsons LL, Demeure MJ, Wilson S, Malycha P, Jones J, Krzywda B 2002 Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 26:942-949
59. Sheldon DG, Lee FT, Neil NJ, Ryan Jr JA 2002 Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137:1022-1026; discussion, 1026-1028
60. Quiros RM, Alef MJ, Wilhelm SM, Djuricin G, Loviscek K, Prinz RA 2003 Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 134:675-681; discussion, 681-683
61. Chiang CY, Andrewes DG, Anderson D, Devere M, Schweitzer I, Zajac JD 2005 A controlled prospective study of neuropsychological outcomes post parathyroidectomy in PHPT. Clin Endocrinol (Oxf) 62:99-104
62. Cogan MG, Covey CM, Arieff AI, Wisniewski A, Clark OH, Lazarowitz V, Leach W 1978 Central nervous system manifestations of hyperparathyroidism. Am J Med 65(6)963-970
63. Goyal A, Chumber S, Tandon N, Lal R, Srivastava A, Gupta S 2001 Neuropsychiatric manifestations in patients of primary hyperthyroidism and outcome following surgery. Indian J Med Sci 55:677-686
64. Coker LH, Rorie K, Cantley L, Kirkland K, Stump D, Burbank N, Tembreull T, Williamson J, Perrier N 2005 Primary hyperparathyroidism, cognition and health related quality of life. Ann Surg 242:642-648
65. Mjaland O, Normann E, Halvorsen E, Rynning S, Egeland T 2003 Regional cerebral blood flow in patients with primary hyperparathyroidism before and after successful parathyroidectomy. Br J Surg 90:732-737
66. Perrier ND, Coker LH, Rorie KD, Burbank NS, Kirkland KA, Passmore LV, Tembreull T, Stump DA, Laurienti PJ 2006 Preliminary report: functional MRI of the brain may be the ideal tool for evaluating neuropsychologic and sleep complaints of patients with primary hyperparathyroidism. World J Surg 30:686-696
67. Rao DS, Philips ER, Divind GW, Talpos GB 2004 Randomized controlled clinical trial of surgery versus no surgery in patients with mild PHPT. J Clin Endocrinol Metab 89:5415-5422
68. Bollerslev J, Jansson S, Mollerup CL, Nordenstrom J, Lundgren E, Tørring O, Varhaug J-E, Baranowski M, Aanderud S, Franco C, Freyschuss B, Isaksen GA, Ueland T, Rosen T, on behalf of the SIPH Study Group 2007 Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92:1687-1692
69. Ambrogini E, Cetani F, Cianferotti L, Vignali E, Banti C, Viccica G, Oppo A, Miccoli P, Berti P, Bilezikian JP, Pinchera A, Marcocci C 2007 Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92:3114-3121
70. Albright F, Reifenstein EC 1948 The parathyroid glands and metabolic bone disease. Baltimore: Williams, Wilkins
71. Heath 3rd H, Hodgson SF, Kennedy MA 1980 Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med 302:189-193
72. Scholz DA, Purnell DC 1981 Asymptomatic primary hyperparathyroidism. 10-year prospective study. Mayo Clin Proc 56:473-478
73. Rao DS, Wilson RJ, Kleerekoper M, Parfitt AM 1988 Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course. J Clin Endocrinol Metab 67:1294-1298
74. NIH Conference 1991 Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 114:593-597
75. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilesikian JP 1999 A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341:1249-1255
76. Silverberg SJ, Brown I, Bilezikian JP 2002 Age as a criterion for surgery in primary hyperparathyroidism. Am J Med 113:681-684
77. Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, Udesky J, Silverberg SJ 2008 The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 93:3462-3470
78. Vestergaard P, Mollerup CL, Frokjaer VG, Christiansen P, Blichert-Toft M, Mosekilde L 2000 Cohort study of risk fracture before and after surgery for primary hyperparathyroidism. BMJ 321:598-602
79. Vestergaard P, Mosekilde L 2003 Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients. World J Surg 27:343-349
80. Vestergaard P, Mosekilde L 2004 Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study. J Int Med 255:108-114
81. Vestergaard P, Mosekilde L 2003 Cohort study on the effect of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ 327:530-534
82. Lundgren E, Rastad J, Thurfjell E, Akerstron G 1997 Population based screening for PHPT with serum calcium and PTH values in menopausal women. Surgery 121:287-294
83. Lundgren E, Hagstrom EG, Lundin J, Winnerback K, Roos J, Ljunghall S, Rastad J 2002 Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population based screening 8 years ago. World J Surg 26:931-936
84. Tordjman KM, Greenman Y, Osher E, Shenkerman G, Sern N 2004 Characterization of normocalcemic primary hyperparathyroidism. Am J Med 117:861-863
85. Lowe H, McMahon DJ, Rubin MR, Bilezikian JP, Silverberg SJ 2007 Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab 92:3001-3005
86. Odvina CV, Sakhaee K, Heller HJ, Peterson RD, Poindexter JR, Padalino PK, Pak CY 2007 Biochemical characterization of primary hyperparathyroidism with and without kidney stones. Urol Res 35:123-128
87. Peacock M, Robertson WG 1989 Urinary calcium stone disease. In: DeGroot LJ, Besser GB, Cahill Jr GF, Marshall JC, Nelson DH, Odell WD, Potts Jr JT, Rubenstein AH, Steinberger E, eds. Endocrinology. 2nd ed. Philadelphia: WB Saunders Company; 1111-1132
88. Peacock M 2002 Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. J Bone Miner Res 17(Suppl 2): N87-N94
89. Bulusu L, Hodgkinson A, Nordin BEC, Peacock M 1970 Urinary excretion of calcium and creatinine in relation to age and body weight in normal subjects and patients with renal calculi. Clin Sci 38:601-612
90. Albright F, Aub JC, Bauer W 1934 Hyperparathyroidism: a common and polymorphic condition as illustrated by seventeen proved cases from one clinic. JAMA 102:1276-1287
91. Miller PD, Bilezikian JP 2002 Bone densitometry in asymptomatic primary hyperparathyroidism. J Bone Miner Res 17:N98-N102
92. Silverberg SJ, Bilezikian JP 1996 Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab 81:2036-2040
93. WHO Study Group on Assessment of Fracture Risk and its Application to Screening for Postmenopausal Osteoporosis 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Tech Rep Ser 843. Geneva: World Health Organization
94. Silverberg SJ, Locker FG, Bilezikian JP 1996 Vertebral osteopenia: a new indication for surgery in primary hyperparathyroidism. J Clin Endocrinol Metab 81:4007-4012
95. Khosla S, Melton III LJ 2002 Fracture risk in primary hyperparathyroidism. J Bone Miner Res 17:N103-N107
96. Abugassa S, Nordenstrom J, Eriksson S, Mollerstrom G, Alveryd A 1990 Skeletal remineralization after surgery for primary and secondary hyperparathyroidism. Surgery 107:128-133
97. Valdemarsson S, Lindergard B, Tibblin S, Bergenfelz A 1998 Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease. J Intern Med 243:115-122
98. Eriksen EF 2002 Primary hyperparathyroidism: lessons from bone histomorphometry. J Bone Miner Res 17:N95-N97
99. Dempster DW, Muller R, Zhou H, Kohler T, Shane E, Parisien M, Silverberg SJ, Bilezikian JP 2007 Preserved three-dimensional cancellous bone structure in mild primary hyperparathyroidism. Bone 41:19-24
100. Roschger P, Dempster DW, Zhou H, Paschalis EP, Silverberg SJ, Shane E, Bilezikian JP, Klaushofer K 2007 New observations on bone quality in mild primary hyperparathyroidism as determined by quantitative backscattered electron imaging. J Bone Miner Res 22:717-723
101. Tamura Y, Araki A, Chiba Y, Mori S, Hosoi T, Horiuchi T 2007 Remarkable increase in lumbar spine bone mineral density and amelioration in biochemical markers of bone turnover after parathyroidectomy in elderly patients with primary hyperparathyroidism: a 5-year follow-up study. J Bone Miner Metab 25:226-231
102. Chen Q, Kaji H, Iu MF, Nomura R, Sowa H, Yamauchi M, Tsukamoto T, Sugimoto T, Chihara K 2003 Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects. J Clin Endocrinol Metab 88:4655-4658
103. Charopoulos I, Tournis S, Trovas G, Raptou P, Kaldrymides P, Skarandavos G, Katsalira K, Lyritis GP 2006 Effect of primary hyperparathyroidism on volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in postmenopausal women. J Clin Endocrinol Metab 91:1748-1753
104. Bonnick SL, Johnston Jr CC, Kleerekoper M, Lindsay R, Miller P, Sherwood L, Siris E 2001 Importance of precision in bone density measurements. J Clin Densitom 4:105-110
105. Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S 2008 Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2007 Position Development Conference. J Clin Densitom 11:75-91
106. Shepherd JA, Lu Y, Wilson K, Fuerst T, Genant H, Hangartner TN, Wilson C, Hans D, Leib ES 2006 Cross-calibration and minimum precision standards for dual-energy x-ray absorptiometry: the 2005 ISCD official positions. J Clin Densitom 9:31-36